$22.220
+0.851 (+3.83%)收盤時
價格預測
在 App 中開啟以解鎖更長週期的預測。
該買進 Attovia Therapeutics Inc 股票嗎？
Attovia Therapeutics, Inc. is a good buy right now due to its recent successful IPO that raised approximately $289 million, reflecting strong market interest. The stock is currently priced at $20.70, which is significantly lower than the analyst price target of $25, suggesting a potential upside of about 20.5%. Additionally, the forward P/E ratio of 4.81 indicates that the stock may be undervalued compared to future earnings expectations. However, the main risk is the negative net income reported for Q1 2026, which stands at -18.66 million USD, indicating ongoing financial challenges.
ATTO 股價於 Tuesday 收在 $22.22，此前上漲 +3.83%
Attovia Therapeutics Inc (ATTO) last closed at $22.22, gaining +3.83%. These facts feed the 1-day and 1-week ATTO price prediction above.
預測驅動因素
Attovia Therapeutics Inc（ATTO）的預測驅動因素綜合了相似的圖表形態、季節性與移動平均線。
Seasonality
Bullish
ATTO 季節性分析
本頁僅供研究參考，不構成投資建議。模型可能出錯。過往表現不代表未來結果。